Bacher, Vera; Shumilov, Evgenii; Pabst, Thomas (2024). Increasing insight in the value of repetitive COVID-19 vaccination in patients with haematological malignancies in the Omicron era. British journal of haematology, 204(2), pp. 386-388. Wiley 10.1111/bjh.19221
Text
Br_J_Haematol_-_2023_-_Bacher_-_Increasing_insight_in_the_value_of_repetitive_COVID_19_vaccination_in_patients_with.pdf - Published Version Restricted to registered users only Available under License Publisher holds Copyright. Download (199kB) |
The study by Kevlicius et al. from Lithuania gives further confirmation of the efficacy of booster mRNA COVID-19 vaccination for patients with haemato-oncological malignancies in the Omicron era. The risk of COVID-19 and mortality was considerably reduced when patients received the booster vaccination. The threshold of the humoral response to vaccination that was protective for haemato-oncological patients was defined. In particular, ruxolitinib and anti-CD20 treatments limited the humoral response to the third booster vaccination. These data may influence the clinical management of haemato-oncological patients in future waves of the COVID-19 pandemic, regarding for example the selection of patients for passive immunization against SARS-CoV-2. Commentary on: Kevličius et al. Immunogenicity and clinical effectiveness of mRNA vaccine booster against SARS-CoV-2 Omicron in patients with haematological malignancies: A national prospective cohort study. Br J Haematol 2023 (Online ahead of print). doi: 10.1111/bjh.19126.
Item Type: |
Journal Article (Further Contribution) |
---|---|
Division/Institute: |
04 Faculty of Medicine > Department of Haematology, Oncology, Infectious Diseases, Laboratory Medicine and Hospital Pharmacy (DOLS) > Clinic of Haematology and Central Haematological Laboratory 04 Faculty of Medicine > Department of Haematology, Oncology, Infectious Diseases, Laboratory Medicine and Hospital Pharmacy (DOLS) > Clinic of Medical Oncology |
UniBE Contributor: |
Bacher, Vera Ulrike, Pabst, Thomas Niklaus |
Subjects: |
600 Technology > 610 Medicine & health |
ISSN: |
1365-2141 |
Publisher: |
Wiley |
Language: |
English |
Submitter: |
Pubmed Import |
Date Deposited: |
22 Nov 2023 10:16 |
Last Modified: |
08 Feb 2024 00:14 |
Publisher DOI: |
10.1111/bjh.19221 |
PubMed ID: |
37984996 |
Uncontrolled Keywords: |
Omicron haematologic malignancies repetitive COVID-19 vaccination |
BORIS DOI: |
10.48350/189245 |
URI: |
https://boris.unibe.ch/id/eprint/189245 |